Aridis Pharmaceuticals Inc (NASDAQ:ARDS)
| 1.31 Delayed Data As of Jun 24 |  -0.05 / -3.68%Today’s Change | 0.88 Today|||52-Week Range 7.72 | -43.78% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Assets | Cash | 13.5M | 34.1M | 24.2M | 16.3M | |
| Short Term Investment Cash | -6.9M | 20.6M | -9.8M | -7.9M | ||
| Cash & Short Term Investments | 13.5M | 34.1M | 24.2M | 16.3M | ||
| Receivables | Receivables | 0.00 | 800.0K | 1.7M | 2.1M | |
| Inventories | Inventories | -- | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 960.0K | 1.4M | 2.5M | 2.1M | |
| Current Assets | 14.4M | 36.3M | 28.3M | 20.5M | ||
| Total Assets | Property, Plant and Equipment - Gross | 1.6M | 1.6M | 1.8M | 1.8M | |
| Depreciation | -337.0K | -410.0K | -491.0K | -572.0K | ||
| Intangible Assets | 41.0K | 39.0K | 38.0K | 36.0K | ||
| Other Assets | 386.0K | 80.0K | 1.0M | 1.0M | ||
| Total Assets | 16.1M | 38.6M | 31.6M | 23.3M | ||
| Liabilities | Accounts Payable | 610.0K | 1.8M | 2.3M | 2.7M | |
| Accrued Expenses | 2.2M | 4.7M | 2.7M | 1.7M | ||
| Other Current Liabilities | 2.9M | 5.2M | 2.7M | 1.7M | ||
| Other Liabilities | 5.1M | 7.2M | 5.3M | 4.5M | ||
| Total Liabilities | Other Liabilities | 8.8M | 0.00 | 0.00 | 0.00 | |
| Total Liabilities | 13.9M | 7.2M | 5.3M | 4.5M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 74.2M | 0.00 | 0.00 | 0.00 | ||
| Common Equity | -72.0M | 31.4M | 26.3M | 18.7M | ||
| Total Shareholder Equity | 2.2M | 31.4M | 26.3M | 18.7M | ||
| Share Information | Common Shares Outstanding | 8.2M | 8.1M | 8.1M | 8.1M | |
| Addtl. Info. | No data currently available for this section. | |||||
